Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has shown remarkable effectiveness for weight loss when used at higher doses. Most people starting semaglutide for weight management begin at 0.25 milligrams weekly, with increases every four weeks as their body adapts to the medication. Understanding how dose escalation works helps set realistic expectations for both side effects and long-term weight loss outcomes.
How Semaglutide Dosing Works for Weight Management
Semaglutide dosing follows a structured titration schedule designed to help your body adjust while reducing nausea and gastrointestinal discomfort. You start at the lowest therapeutic dose—typically 0.25 milligrams injected subcutaneously once weekly—then increase by 0.25 milligrams each week for four weeks until reaching 1 milligram. This gradual approach allows your digestive system and appetite-regulating hormones to acclimate without overwhelming your body with sudden hormonal changes.
After reaching the 1 milligram maintenance dose, some patients continue increasing to 1.7 or 2.4 milligrams weekly based on clinical response and tolerance. The maintenance phase typically lasts 12 to 16 weeks before your prescriber determines if a higher dose would yield additional weight loss benefits. Research from the STEP trials showed that participants losing the most weight were those who remained compliant with higher maintenance doses over extended periods.
Starting Semaglutide: The First Month Timeline
Your first four weeks of semaglutide treatment involve weekly dose increases that mirror how the medication was tested in clinical trials. Week one uses 0.25 milligrams to establish baseline tolerance; week two escalates to 0.5 milligrams; week three reaches 0.75 milligrams; and week four completes the initial titration at 1 milligram weekly. Most patients notice appetite suppression and early weight loss beginning around week two, though the full satiety effect develops more prominently by week four.
During this initial month, keeping a symptom log helps you and your prescriber track how your body responds to each dose increment. Common early-phase side effects include mild nausea, constipation, and reduced appetite—all expected responses as your GLP-1 receptors become more sensitive to the medication. PlexusDx patients receive guidance on nutrition timing and hydration strategies that significantly reduce gastrointestinal disruption during the titration phase.
Maintenance Doses and Long-Term Weight Loss Results
Once you complete the initial four-week titration, maintenance doses of 1 milligram represent the most common therapeutic level for weight management according to published clinical data. However, individual response varies significantly based on genetics, metabolism, and body composition—which is why PlexusDx offers the Precision Peptide Genetic Test to identify your genetic variants affecting GLP-1 receptor sensitivity and peptide metabolism. Patients with specific variants in the GLP1R gene may achieve optimal results at lower maintenance doses, while others benefit from escalation to 1.7 or 2.4 milligrams.
The STEP 1 trial demonstrated that participants on 2.4 milligrams of semaglutide lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% in the placebo group. Most weight loss occurs during months two through six of treatment, with continued but slower loss continuing through month twelve. Maintaining your dose consistently week to week proves more important for sustained results than pursuing higher doses irregularly.
PlexusDx Semaglutide: Fixed Pricing Across All Dose Levels
PlexusDx compounded semaglutide injections start at $149 per month, with your dose able to increase without price changes—ensuring your therapy adapts to your body's needs without financial barriers. Unlike insurance-based or retail models that may adjust costs based on dose strength, PlexusDx maintains transparent, flat-rate pricing across the three commitment tiers. This pricing model removes the financial pressure to stay on lower doses when your prescriber recommends escalation for better outcomes.
All PlexusDx medications are prepared by licensed 503A compounding pharmacies meeting FDA standards for purity, potency, and sterility. Treatment is available in all 50 states without insurance requirements, and semaglutide injections are HSA and FSA eligible, offering additional savings for qualified accounts. Your initial month may include the optional Precision Peptide Genetic Test ($99 add-on) to map 14 metabolic pathways and identify personalized dose optimization based on your genetic profile.
Side Effects and Dose Tolerance Management
Gastrointestinal side effects peak during the titration phase but typically diminish by week six as your digestive system adapts to GLP-1 activation. Nausea, constipation, and mild stomach discomfort are dose-related and usually resolve with slower dose increases, adequate water intake, and dietary adjustments favoring lean proteins and soluble fiber. Severe side effects requiring dose reduction are rare but include persistent vomiting or signs of dehydration—conditions that warrant immediate communication with your PlexusDx prescriber.
A small percentage of patients experience pancreatitis symptoms (severe upper abdominal pain, vomiting) or gallbladder complications, which require immediate medical attention and therapy discontinuation. Your prescriber screens for personal or family history of medullary thyroid cancer and multiple endocrine neoplasia syndrome type 2 before initiating semaglutide, as these conditions represent contraindications. Monthly check-ins during titration help identify tolerability issues early, allowing dose adjustments or temporary pauses to ensure safety.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 milligrams injected subcutaneously once per week, increased by 0.25 milligrams each week for four weeks until reaching 1 milligram. PlexusDx prescribers follow this evidence-based titration schedule to minimize side effects while establishing therapeutic response, with ongoing assessment for dose optimization.
How much weight can you lose on semaglutide, and does dose affect results?
Clinical trials show average weight loss of 9.2% at 1 milligram and 14.9% at 2.4 milligrams over 68 weeks compared to 2.4% with placebo. Higher maintenance doses generally correlate with greater weight loss, though individual genetics and metabolic factors significantly influence outcomes—information PlexusDx Precision Peptide Genetic Testing can illuminate.
Is PlexusDx semaglutide the same flat price at every dose level?
No. PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across all dose levels—your dose may increase, but your price won't. This model removes financial barriers to dose optimization and works across all 50 states with HSA/FSA eligibility.
What side effects occur at higher semaglutide doses, and are they dangerous?
Nausea, constipation, and appetite loss intensify with dose increases but typically resolve within one to two weeks as your body adapts. Serious side effects like pancreatitis or severe dehydration are rare; your PlexusDx prescriber screens for risk factors beforehand and monitors you monthly to catch complications early.
Can genetic testing help determine my optimal semaglutide dose?
Yes. PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, and appetite-related genes that influence how your body responds to semaglutide, mapping 14 pathways across 49 peptides to guide personalized dosing. This $99 add-on after your first month helps predict which dose level will deliver maximum results for your unique physiology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Will I Lose with Wegovy?
Navigating Heartburn on Your Weight Loss Journey: Can You Take Famotidine With Ozempic?